报价延迟最少15分钟:2026/01/08 17:08 EST
盘后时段
|
||||
|
8.02 
|
|
|
常规时段 (已结束)
|
|
|
|
|
||||||||||||
|
|
|
|
|
8.02
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-2.87/-1.53
|
|
企业价值
162.17M
|
| 资产负债 |
|
每股账面净值
-1.07
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
7.57M
|
|
每股收益
0.54
|
|
同行比较
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts. |
